Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026盛德助力华曦达科技于香港联交所主板成功上市May 27, 2026Sidley Represents Peach Finance in Its Acquisition by SoFiMay 26, 2026盛德助力驭势科技成功完成香港18C章项下上市项目May 20, 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory